Aline Clavert

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Delphine Rossille, M Gréssier, Diane Damotte et al. · Leukemia · 2014 · 324 citations

Medicine, Hematology, Oncology +14

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

Carole Soussain, Sylvain Choquet, Marie Blonski et al. · European Journal of Cancer · 2019 · 318 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Nicole Wong Doo, Carole Soussain, Sylvain Choquet et al. · UCL Discovery (University College London) · 2022 · 76 citations

Medicine, Pharmacology, Pharmacotherapy +10

Impact of the hypomethylating agent 5-azacytidine on dendritic cells function

Jihane Frikeche, Aline Clavert, Jacques Delaunay et al. · Experimental Hematology · 2011 · 58 citations · Full text

Life Sciences, Immunology, Pharmacology +13